Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride provides potassium ions, essential for maintenance of intracellular tonicity, nerve impulse transmission, cardiac, smooth, and skeletal muscle contraction, and acid-base balance. Dextrose 10% provides caloric supplementation, and sodium chloride 0.2% provides sodium and chloride ions to maintain electrolyte balance.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion, rate determined by severity of hypokalemia and patient condition; typical adult dose: 10-20 mEq potassium chloride per hour, not to exceed 40 mEq/hour or 200 mEq/day; solution provides 10 mEq potassium per liter at 0.075% concentration.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium: Not applicable as a drug; physiological half-life of potassium in the body is approximately 30 hours (whole-body turnover). Dextrose: rapid metabolism, half-life <15 minutes. Sodium chloride: not applicable (electrolyte).
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% of potassium and chloride ions are excreted by the kidneys. Dextrose is metabolized to CO2 and water, with minimal excretion unchanged (<5% renal). Sodium chloride is renally excreted (sodium >95% reabsorbed under normal conditions).
Category C
Category A/B
Electrolyte
Electrolyte